State Key Laboratory for Infectious Diseases Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Department of Medicine, Hunan Traditional Chinese Medical College, Zhuzhou, China.
Antimicrob Agents Chemother. 2017 Dec 21;62(1). doi: 10.1128/AAC.01279-17. Print 2018 Jan.
The EmbCAB proteins have been considered a target for ethambutol (EMB). Mutations in are known to confer most EMB resistance. However, the knowledge about the effects of mutations on the EMB resistance level and about the role of mutation-mutation interactions is limited in China. Here, we sequenced among 125 isolates from China and quantified their EMB MICs by testing growth at 10 concentrations. Furthermore, a multivariate regression model was established to assess the effects of both individual mutations and multiple mutations. Our results revealed that in China, 82.6% of EMB-resistant isolates (71/86 isolates) harbored at least one mutation within Most of the mutations were located in the and upstream region. Several individual mutations and multiple mutations within this region contributed to the different levels of EMB resistance. Their effects were statistically significant. Additionally, there was an association between high-level EMB resistance and multiple mutations.
EmbCAB 蛋白被认为是乙胺丁醇(EMB)的靶标。已知 中的突变赋予了大多数 EMB 耐药性。然而,关于 突变对 EMB 耐药水平的影响以及突变-突变相互作用的作用在中国的了解有限。在这里,我们对来自中国的 125 个分离株中的 进行了测序,并通过测试在 10 种浓度下的生长来定量它们的 EMB MIC。此外,建立了一个多变量回归模型来评估单个突变和多个突变的影响。我们的结果表明,在中国,82.6%的 EMB 耐药分离株(71/86 株)至少在 中携带一个突变。大多数突变位于 和 上游区域。该区域内的几个单个突变和多个突变导致了不同水平的 EMB 耐药性。它们的影响具有统计学意义。此外,高水平的 EMB 耐药性与多个突变之间存在关联。